Stay updated on Nivolumab with/without Ipilimumab in Advanced Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with/without Ipilimumab in Advanced Kidney Cancer Clinical Trial page.

Latest updates to the Nivolumab with/without Ipilimumab in Advanced Kidney Cancer Clinical Trial page
- CheckyesterdayChange DetectedSite-wide funding notice and system revision updated to v3.4.1, replacing v3.4.0 in the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check8 days agoChange DetectedThe study history page now includes a glossary toggle, color-coding explanations for additions and deletions, and updated revision metadata such as Revision: v3.4.0 with corresponding dates.SummaryDifference0.9%

- Check15 days agoChange DetectedMinor version upgrade from v3.3.3 to v3.3.4 was applied with no changes to study data, status, or visible content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedFooter updates were made. The HHS Vulnerability Disclosure link was removed and a new Revision: v3.3.3 was added, while Revision: v3.3.2 was removed.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision: v3.3.2 added to the history and revision: v3.3.1 removed.SummaryDifference0.1%

- Check74 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.1. No substantive changes to the study record or its public presentation are visible.SummaryDifference0.1%

Stay in the know with updates to Nivolumab with/without Ipilimumab in Advanced Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with/without Ipilimumab in Advanced Kidney Cancer Clinical Trial page.